These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 19402863)
1. Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity. Keskin M; Dolar E; Dirican M; Kiyici M; Yilmaz Y; Gurel S; Nak SG; Erdinc S; Gulten M Intern Med J; 2009 Apr; 39(4):243-8. PubMed ID: 19402863 [TBL] [Abstract][Full Text] [Related]
2. Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus. Ali EM; Shehata HH; Ali-Labib R; Esmail Zahra LM Clin Biochem; 2009 Sep; 42(13-14):1394-400. PubMed ID: 19538950 [TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis. Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991 [TBL] [Abstract][Full Text] [Related]
4. PON1 status in haemodialysis patients and the impact of hepatitis C infection. Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792 [TBL] [Abstract][Full Text] [Related]
5. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479 [TBL] [Abstract][Full Text] [Related]
6. Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities. Schulpis KH; Barzeliotou A; Papadakis M; Rodolakis A; Antsaklis A; Papassotiriou I; Vlachos GD Clin Biochem; 2008 Mar; 41(4-5):282-7. PubMed ID: 18035058 [TBL] [Abstract][Full Text] [Related]
7. Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B. Mogarekar MR; Talekar SJ Indian J Gastroenterol; 2013 Sep; 32(5):307-10. PubMed ID: 23700138 [TBL] [Abstract][Full Text] [Related]
8. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. Dirican M; Akca R; Sarandol E; Dilek K J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056 [TBL] [Abstract][Full Text] [Related]
9. Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease. Paragh G; Seres I; Harangi M; Pocsai Z; Asztalos L; Locsey L; Szeles G; Kardos L; Varga E; Karpati I; Adany R Nephron Clin Pract; 2009; 113(1):c46-53. PubMed ID: 19602899 [TBL] [Abstract][Full Text] [Related]
10. Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. Elkiran ET; Mar N; Aygen B; Gursu F; Karaoglu A; Koca S BMC Cancer; 2007 Mar; 7():48. PubMed ID: 17362500 [TBL] [Abstract][Full Text] [Related]
11. Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus. Juretić D; Motejlkova A; Kunović B; Rekić B; Flegar-Mestrić Z; Vujić L; Mesić R; Lukac-Bajalo J; Simeon-Rudolf V Acta Pharm; 2006 Mar; 56(1):59-68. PubMed ID: 16613735 [TBL] [Abstract][Full Text] [Related]
12. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810 [TBL] [Abstract][Full Text] [Related]
13. Oxidative status and serum PON1 activity in beta-thalassemia minor. Selek S; Aslan M; Horoz M; Gur M; Erel O Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936 [TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 arylesterase activity and mass are reduced and inversely related to C-reactive protein in patients on either standard or home nocturnal hemodialysis. Kannampuzha J; Darling PB; Maguire GF; Donnelly S; McFarlane P; Chan CT; Connelly PW Clin Nephrol; 2010 Feb; 73(2):131-8. PubMed ID: 20129020 [TBL] [Abstract][Full Text] [Related]
16. Paraoxonase phenotype distribution in a healthy Iranian population. Sepahvand F; Shafiei M; Ghaffari SM; Rahimi-Moghaddam P; Mahmoudian M Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311 [TBL] [Abstract][Full Text] [Related]
17. Paraoxonase and arylesterase activities in coronary artery disease. Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345 [TBL] [Abstract][Full Text] [Related]
18. Arylesterase and paraoxonase activity of paraoxonase (PON1) affected by ischemia in the plasma of patients with arterial occlusion of the lower limbs. Kasprzak M; Iskra M; Majewski W; Wielkoszyński T Clin Biochem; 2009 Jan; 42(1-2):50-6. PubMed ID: 18976644 [TBL] [Abstract][Full Text] [Related]
19. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease]. Gamboa R; Regalado JC; Huesca-Gómez C; Posadas-Romero C; Verdejo Paris J; Vargas-Alarcón G; Pérez-Méndez O Arch Cardiol Mex; 2008; 78(4):360-8. PubMed ID: 19205543 [TBL] [Abstract][Full Text] [Related]
20. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus. Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]